-
Innovation Ranking
NewInnovation Ranking – Y-mAbs Therapeutics Inc
Y-mAbs Therapeutics Inc(Y-mAbs) is a clinical biopharmaceutical company. It develops and commercializes novel antibody therapeutic products for cancer treatment. The Company technologies include bispecific antibodies generated using the Y-BiClone platform and the SADA platform. The Company product pipeline includes DANYELZA (naxitamab-gqgk), which targets tumors that express GD2, and omburtamab, which targets tumors that express B7-H3. DANYELZA is a humanized monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment of in the bone or bone marrow stable disease...
-
Innovation Ranking
NewInnovation Ranking – Molibdenos y Metales S.A.
Molibdenos y Metales SA (Molibdenos) is a metals and mining company. It carries out the treatment and processing of molybdenum and related products. The company offers various products such as molybdic oxide (powder), technical grade molybdic oxide (briquettes), Molybdic oxide (sandy grade), Molybdic oxide (floury grade), Molybdenum metal powder, Molybdenum metal powder high density, and Molybdenum metal briquettes. Molibdenos also provides copper cement, copper cathodes and sulfuric acid. Molibdenos produces products for steel, chemical, and metallic and superalloy industries. It...
-
Innovation Ranking
NewInnovation Ranking – Actividades de Construccion y Servicios SA
Actividades de Construccion y Servicios SA (ACS) is a construction contracting company. It offers a range of infrastructure and energy construction and other related services globally. The company carries out infrastructure development; residential and social infrastructure construction works; civil works; building projects, and implementation of works for mining projects. It also offers applied engineering services and the installation and maintenance services for industrial infrastructure such as power plants, industrial and telecommunications systems; and offers urban services and waste treatment services....
-
Innovation Ranking
NewInnovation Ranking – Fomento de Construcciones y Contratas SA
Fomento de Construcciones y Contratas SA (FCC), a subsidiary of Control Empresarial de Capitales SA de CV, is a citizen services company, which provides services in environmental, water, and infrastructure development sectors. The company manages and treats domestic and industrial waste; provides integrated water management services; and designs, develops and maintains infrastructure. The company provides engineering and construction services for civil works, and residential and non-residential building works; and produces cement, concrete, aggregate, and mortar. It serves environmental, water, and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Y-3 in Depression
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Y-3 in Depression report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Y-3 in Depression Drug Details: Y-3 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Y-101D in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Y-101D in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Y-101D in Gastric Cancer Drug Details: Bi-specific monoclonal antibody is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Y-101D in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Y-101D in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Y-101D in Solid Tumor Drug Details: Bi-specific monoclonal antibody is under...
-
Product Insights
Craig Y Perthi Solar Farm, UK
Craig Y Perthi Solar Farm is proposed to be developed in England, United Kingdom. Empower your strategies with our Craig Y Perthi Solar Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Y-150 in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Y-150 in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Y-150 in Relapsed Multiple Myeloma Drug Details: Y-150 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Y-150 in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Y-150 in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Y-150 in Refractory Multiple Myeloma Drug Details: Y-150 is under development...